Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baiya SARS-CoV-2 Vax 2 Booster in Adults
NCT05873374Phase 2Not yet recruiting
- Sponsor
- Baiya Phytopharm
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Baiya SARS-CoV-2 Vax 2 in coronavirus disease 2019 (COVID-19), sponsored by Baiya Phytopharm. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Baiya SARS-CoV-2 Vax 2
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05873374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05873374.